MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Assessment of pain in Parkinson’s disease: comparison between clinical and self-reported measures

C. Rodriguez-Blazquez, R. Balestrino, K. Chaudhuri, J.M. Rojo-Abuin, A. Rizos, C. Trenkwalder, A. Sauerbier, P. Odin, A. Antonini, P. Martinez-Martin (Madrid, Spain)

Meeting: 2017 International Congress

Abstract Number: 45

Keywords: Non-motor Scales, Pain

Session Information

Date: Monday, June 5, 2017

Session Title: Parkinson's Disease: Non-Motor Symptoms

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: To compare the performance of several pain measures, self- and rater-based, in PD patients.

Background: Pain is a prevalent and complex symptom in Parkinson’s disease (PD). Several scales are available to assess pain in PD, including patient-reported outcomes and rater-based scales, such as the King’s Parkinson’s Disease Pain Scale (KPPS). 

Methods: Data were extracted from the KPPS validation study (Chaudhuri et al, 2015). Pain assessment was made by self-administered (visual analogue scale –VAS- for pain, and EQ-5D and PDQ-8 items for pain), and rater-based measures (KPPS and NMSS item for pain). Other validated rating scales for PD symptoms assessment were also applied. Data analysis included correlation coefficients, comparison of pain scores between groups according to variables of interest and multivariate linear regression models with KPPS and VAS-pain as dependent variables.

Results: The sample was composed by 178 PD patients with non-explained pain. Mean age was 64.38 years (SD: 11.38) and disease duration, 5.4 (SD: 4.93). Patients were mainly in HY stage 2 (47.7%). Correlation coefficients between pain scales were low to moderate: from 0.21 (NMSS item 27 with KPPS) to 0.54 (KPPS with VAS-pain). KPPS obtained the highest correlation coefficients with the rest of measures: 0.64 with PDSS and 0.59 with NMSS. VAS-pain correlated 0.51 with global severity of PD (CISI-PD). All measures of pain showed the highest scores in patients with longest disease duration. Only KPPS and VAS-pain showed significant differences according to disease severity (HY). No significant differences in pain scores were found in relation to sex, age and age at onset. In the regression models, KPPS and VAS-pain showed associations with sleep disorders and motor symptoms, controlling for other variables.

Conclusions: Pain measures KPPS and VAS-pain showed the strongest associations with other clinical variables in PD. Our results suggest that pain assessment in PD should be done with a combination of rater- and patient-based measures.

References: Chaudhuri KR, Rizos A, Trenkwalder C, Rascol O, Pal S, Martino D, Carroll C, Paviour D, Falup-Pecurariu C, Kessel B, Silverdale M, Todorova A, Sauerbier A, Odin P, Antonini A, Martinez-Martin P; EUROPAR and the IPMDS Non Motor PD Study Group.. King’s Parkinson’s disease pain scale, the first scale for pain in PD: An international validation. Mov Disord. 2015 Oct;30(12):1623-31. doi: 10.1002/mds.26270.

To cite this abstract in AMA style:

C. Rodriguez-Blazquez, R. Balestrino, K. Chaudhuri, J.M. Rojo-Abuin, A. Rizos, C. Trenkwalder, A. Sauerbier, P. Odin, A. Antonini, P. Martinez-Martin. Assessment of pain in Parkinson’s disease: comparison between clinical and self-reported measures [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/assessment-of-pain-in-parkinsons-disease-comparison-between-clinical-and-self-reported-measures/. Accessed December 10, 2023.
  • Tweet
  • Email
  • Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/assessment-of-pain-in-parkinsons-disease-comparison-between-clinical-and-self-reported-measures/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Carpal Tunnel Syndrome in Patients with Tremor
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Patients with Essential Tremor Live Longer than their Relatives
  • Carpal Tunnel Syndrome in Patients with Tremor
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Insulin dependent diabetes and hand tremor
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2023 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley